BRAIN Biotech AG BNN
XETR · Germany · Health Technology
€2.850.00 (0.00%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Dr. Sven K. Weber will assume the position of CEO on October 1, 2026 Adriaan Moelker will retire at the end of his contract term as scheduled ZWINGENBERG, GERMANY - July 29, 2026 (NEWMEDIAWIRE) - The Supervisory Board of BRAIN Biotech AG ("BRAIN...
Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organisms Patent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for strain optimizat...
ZWINGENBERG, GERMANY - March 11, 2026 (NEWMEDIAWIRE) - At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr. Ursu...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.